Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Studies on adoptive immunotherapy using recombinant interleukin 2].

Y Sugiyama, H Takao, S Saji

    Gan to Kagaku Ryoho. Cancer & Chemotherapy
    |April 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Utility of computed tomography and <sup>18</sup> F-fluorodeoxyglucose with positron emission tomography/computed tomography for distinguishing appendiceal mucocele caused by mucinous adenocarcinoma from other pathologies.

    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2020
    Same author

    Comparison of hemodynamic parameters that can predict an aneurysmal rupture: 20 patient-specific models experiment.

    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2018
    Same author

    The relationship of waist circumference and body mass index to grey matter volume in community dwelling adults with mild obesity.

    Obesity science & practice·2018
    Same author

    The impact of deformation of an aneurysm model under pulsatile flow on hemodynamic analysis.

    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2017
    Same author

    High-Resolution C-Arm CT and Metal Artifact Reduction Software: A Novel Imaging Modality for Analyzing Aneurysms Treated with Stent-Assisted Coil Embolization.

    AJNR. American journal of neuroradiology·2015
    Same author

    Brain diffusivity pattern is individual-specific information.

    Neuroscience·2015

    Lymphokine-activated killer (LAK) cells show enhanced tumor-killing ability compared to peripheral blood lymphocytes. Gastric cancer sera and immunosuppressive factors have a milder impact on LAK cell cytotoxicity, which can be further boosted by IL2.

    Area of Science:

    • Immunology
    • Cell Biology
    • Oncology

    Context:

    • Investigating the characteristics and therapeutic potential of Lymphokine-Activated Killer (LAK) cells.
    • Assessing the impact of the tumor microenvironment on immune cell function.
    • Exploring novel immunotherapeutic strategies for gastric cancer.

    Purpose:

    • To analyze the monoclonal markers and cytotoxic capabilities of LAK cells.
    • To evaluate the influence of gastric cancer patient serum and immunosuppressive factors on LAK cell activity.
    • To determine the efficacy of Interleukin-2 (IL2) in augmenting LAK cell-mediated tumor cell killing.

    Summary:

    • Monoclonal analysis revealed higher proportions of specific lymphocyte markers in LAK cells compared to peripheral blood lymphocytes (PBL).

    Related Experiment Videos

  • LAK cells demonstrated superior cytotoxic ability against various tumor cell lines than PBL.
  • While immunosuppressive factors and gastric cancer sera reduced cytotoxicity, LAK cells exhibited greater resistance than PBL.
  • IL2 administration significantly enhanced LAK cell cytotoxic activity, with pre-incubation showing further augmentation.
  • Impact:

    • LAK cells possess inherent advantages in anti-tumor immunity over PBL.
    • The findings suggest LAK cells may be more resilient to the immunosuppressive effects in the gastric cancer environment.
    • IL2 holds potential for enhancing LAK cell-based immunotherapies for cancer treatment.